Now live: Pro — the full 13F research suite for serious investorsSee pricing →
COURAGE CAPITAL MANAGEMENT LLC

Q2 2023 · 13F-HR

COURAGE CAPITAL MANAGEMENT LLCholdings as filed

Filed 2023-08-14 · accession 0001567619-23-006939

$36,431
Reported value
17
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
19249HAB9Coherus Biosciences Inc$11,20530.8%18,000,000CommonSOLE
85207H104PHYSSprott Physical Gold Trust$3,94610.8%264,500CommonSOLE
30050BAD3EVH 1.5 10/15/25General Dynamics Corp$3,93410.8%3,434,000CommonSOLE
38150K103AAAUGoldman Sachs Physical Gold$3,5079.63%184,254CommonSOLE
30303M102METAMicrosoft Corp$2,5837.09%9,000CommonSOLE
674215207CHRDChord Energy Inc$1,6924.64%11,000CommonSOLE
444859102HUMHumana Inc$1,5204.17%3,400CommonSOLE
20854L108CEIXEURConsol Energy Inc New$1,5134.15%22,315CommonSOLE
22822V101CCICrown Castle Intl$1,3673.75%12,000CommonSOLE
69327R101PDC Energy Inc$1,2813.52%18,000CommonSOLE
08579X101BRYBerry Corp$1,2773.51%185,600CommonSOLE
464285204IAUJohnson & Johnson Inc$1,0192.80%28,000CommonSOLE
02079K107GOOGAlphabet Inc Class C$6651.83%5,500CommonSOLE
478160104JNJMatinas Biopharma Holdings Inc$3310.91%2,000CommonSOLE
369550108GDGeneral Dynamics Corp$2580.71%1,200CommonSOLE
19249H103CHRSCoherus Biosciences Inc$2140.59%50,000CommonSOLE
576810105MTNBEURMeta Platforms Inc$1190.33%331,846CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.